Consequently, the increase in expression of Mt1 and Mt2, found in Fah-deficient mouse livers under NTBC treatment, could point to an unresolved oxidative stress response against toxic tyrosine metabolites, which might still progress into HCC development. The gene discussed is FAH; the disease is hepatocellular carcinoma.